Hyperlipidemia: Clinical Trials

41 trials for Hyperlipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 9 unknown, 2 terminated, 1 recruiting. 41 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 441Completed 28, Unknown 9, Terminated 2, Recruiting 1, Withdrawn 1

Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia

Trials (filtered) newest first · largest first

All 41 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT
Live Combined Bacillus subtilis and Enterococcus faecium Enteric-coated Capsules (LCBE), Standard Care (in control arm) - Hypertriglyceridemic Acute Pancreatitis, Acute Pancreatitis, Hypertriglyceridemia-induced
Phase 4RecruitingJianyin Zhou1802026-01-182026-07-22
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
Inclisiran - Carotid Plaque, Hyperlipidemia
Phase 4UnknownFirst Affiliated Hospital of Xinjiang Medical University402024-09-202024-09-19
Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
TAK-085, Not treated with omega-3-acid ethyl esters - Hyperlipidemia
Phase 4CompletedTakeda532016-12-272019-02-11
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
Alirocumab - Atherosclerosis, Hyperlipidemia
Phase 4UnknownWestside Medical Associates of Los Angeles352016-11-012019-04-26
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
TAK-085 - Hyperlipidemia
Phase 4CompletedTakeda372016-08-042019-05-06
Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Atorvastatin - Hyperlipidemia, Insulin Resistance
Phase 4CompletedStanford University1152015-05-012021-04-06
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Rosuvastatin(Cresnon®), Rosuvastatin(Crestor®) - Hyperlipidemia
Phase 4CompletedDong-A ST Co., Ltd.2232014-09-012015-07-07
Nutraceuticals to Improve Lipid Profile in European Countries
Non-pharmacologic intervention, Nutraceuticals (Armolipid Plus) - Hyperlipidemia
Phase 4UnknownUniversity of Roma La Sapienza1002014-01-012013-03-07
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
Atorvastatin - Renal Failure Chronic Requiring Hemodialysis, Metabolic Syndrome
Phase 4CompletedPoznan University of Medical Sciences3102011-10-012014-10-07
Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
Rosuvastatin - Hyperlipidemia, Coronary Artery Disease
Phase 4UnknownPeking University First Hospital6002011-03-012011-06-27
Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia
Simvast CR, Zocor - Chronic Kidney Disease, Hyperlipidemia
Phase 4UnknownHanmi Pharmaceutical Company Limited1222010-12-012012-03-28
Telephone Based Management of Hyperlipidemia
Self Monitoring Lipid Analyzer - Hyperlipidemia
Phase 4CompletedTemple University702010-11-012026-04-07
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
Placebo, Colesevelam - Dyslipidemia, Hyperlipidemia
Phase 4CompletedRadiant Research1402010-11-012012-01-06
Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols
Plant sterol, Placebo - Hyperlipidemia
Phase 4CompletedUniversity of Manitoba712010-09-012017-05-09
Effects of Omega-3 Fatty Acids on the Human Gene Expression
Fish oil, Placebo (corn oil) - Hyperlipidemia, Healthy
Phase 4CompletedGottfried Wilhelm Leibniz Universität Hannover402010-03-012011-12-19
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
Atorvastatin, Rosuvastatin - Coronary Artery Disease, Hyperlipidemia
Phase 4CompletedHarbin Medical University1202009-12-012013-09-11
Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
ezetimibe/simvastatin 10/20 mg + placebo, ezetimibe/simvastatin 10/20 mg + MK0524A - Cardiovascular Diseases, Hyperlipidemia
Phase 4WithdrawnInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2009-11-012015-03-24
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
Lipid modification - Hyperlipidemia
Phase 4CompletedYonsei University1802009-03-012011-08-11
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
ezetimibe, fenofibrate, pravastatin - HIV, Hyperlipidemia
Phase 4UnknownOspedale di Circolo - Fondazione Macchi602009-03-012011-08-02
Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
Rosuvastatin (Crestor) - Hyperlipidemia, Atherosclerosis
Phase 4UnknownChinese PLA General Hospital602009-03-012010-05-27

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Hyperlipidemias (41)  ·  Diabetes Mellitus (6)  ·  Hypertension (6)  ·  Cardiovascular Diseases (5)  ·  Coronary Disease (4)  ·  Diabetes Mellitus, Type 2 (3)  ·  Dyslipidemias (3)  ·  HIV Infections (3)  ·  Hyperlipoproteinemia Type II (3)  ·  Atherosclerosis (2)  ·  Coronary Artery Disease (2)  ·  Hypercholesterolemia (2)  ·  Carotid Artery Diseases (1)  ·  Constipation (1)  ·  Hyperglycemia (1)

Broader conditions

Lipid Metabolism Disorders (41)  ·  Metabolic Diseases (41)  ·  Nutritional and Metabolic Diseases (41)  ·  Dyslipidemias (38)  ·  Vascular Diseases (14)  ·  Cardiovascular Diseases (12)  ·  Glucose Metabolism Disorders (9)  ·  Endocrine System Diseases (8)  ·  Heart Diseases (6)  ·  Myocardial Ischemia (6)  ·  Urogenital Diseases (5)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Genital Diseases (4)  ·  Blood-Borne Infections (3)

Interventions

Rosuvastatin Calcium (7)  ·  Atorvastatin (5)  ·  Ezetimibe (4)  ·  Simvastatin (4)  ·  Fenofibrate (3)  ·  Pravastatin (3)  ·  Amlodipine (2)  ·  Colesevelam Hydrochloride (2)  ·  TAK-085 (2)  ·  ALN-PCS (1)  ·  Aripiprazole (1)  ·  Aspirin (1)  ·  Cholesterol (1)  ·  Colestipol (1)  ·  Corn Oil (1)

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3)  ·  Takeda (2)  ·  University of Colorado, Denver (2)  ·  AstraZeneca (1)  ·  Chinese PLA General Hospital (1)  ·  Cynthia West (1)  ·  Dong-A ST Co., Ltd. (1)  ·  First Affiliated Hospital of Xinjiang Medical University (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Gottfried Wilhelm Leibniz Universität Hannover (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Harbin Medical University (1)  ·  In His Image (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)

Countries

United States (13)  ·  China (5)  ·  Italy (4)  ·  Canada (3)  ·  Japan (3)  ·  South Korea (3)  ·  Germany (2)  ·  Mexico (2)  ·  Austria (1)  ·  Belgium (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)  ·  Ireland (1)

Top investigators

Alicja E. Grzegorzewska, MD, PhD (1)  ·  Ana Polanco, MD (1)  ·  Andreas Hahn, Prof. (1)  ·  Barbara Farrell, PharmD (1)  ·  Barbara V Howard, PhD (1)  ·  Bo Yu, MD,PhD (1)  ·  Carlos Posadas-Romero, MD (1)  ·  Charlotte G McDonald, MD (1)  ·  Christina L Aquilante, PharmD (1)  ·  Dario Giugliano, MD,PhD (1)  ·  Dominique Costagliola (1)  ·  Edward Rylander, MD (1)  ·  Elisabeth Aslangul, MD (1)

Results publications

PMID 38018702, PMID 15505289, PMID 16310551, PMID 17011942, PMID 18172039, PMID 18332269, PMID 18398080, PMID 18519429, PMID 18559695, PMID 19095139, PMID 19104004, PMID 19407658, PMID 19423108, PMID 20339536, PMID 20413733, PMID 21593784, PMID 21788602, PMID 21815708, PMID 22269152, PMID 22318219, PMID 22573644, PMID 22621246, PMID 22739396, PMID 22808006, PMID 22929118, PMID 23100216, PMID 23145922, PMID 23241455, PMID 23323877, PMID 24843520, PMID 25022285, PMID 25135178, PMID 25401325, PMID 25670361, PMID 25733626, PMID 26333513, PMID 27165949, PMID 27322530, PMID 27871242, PMID 28196012, PMID 28682990, PMID 28697126, PMID 28848511, PMID 30094622, PMID 30565155, PMID 30629026, PMID 30719003, PMID 31229460, PMID 32200533, PMID 32476785

NIH funding

2005 (1)